ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 221

Emergency Department Utilization for Fibromyalgia Patients

Soumyasri Kambhatla1, Estefania Gauto-Mariotti 2 and AUGUSTINE MANADAN 3, 1John H. Stroger Hospital of Cook County, Chicago, 2Cook County Health, chicago, 3Rush University Medical Center, chicago

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: fibromyalgia and health care cost

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Fibromyalgia & Other Clinical Pain Syndromes Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Fibromyalgia (FMS) is a common pain syndrome affecting millions of people in the USA. It is normally managed in the outpatient setting by rheumatologists, pain physicians, and primary care physicians but some FMS patients seek care in emergency departments (ED). In this abstract, we describe ED visit utilization for patients with FMS based on billing codes.

Methods: Data were abstracted from the National Inpatient Sample Databases. This database is the largest longitudinal collection of inpatient admission and emergency department data in the USA. It is a nationally representative sample from approximately 1000 hospitals.  The numbers in the databases are weighted to optimize both national estimates and longitudinal analysis. The databases were searched for ED visits in 2016 with a listed ICD-10 code for fibromyalgia M79.7 as the principal diagnosis. Total number of FMS ED visits, gender, age, number of hospital admissions, and inpatient charges were recorded.

Results: 16,442 ED visits had an ICD-10 FMS code listed as the principal diagnosis in 2016.   This is estimated to be 5.1 ED FMS visits per 100,000 persons. The age breakdown was as follows:  < 17 =135 (0.82%), 18-44 =7,474 (45.46%), 45-64 = 7,058 (42.93%), and 65-84 =1,676 (10.19%), and ≥85= 98 (0.6%); see table 1. Gender breakdown of ED FMS visits were as follows 15,417 (93.8%) females and 1,020 (6.2%) males; see table 2. Only a small number of ED visits 800/16,442 (4.9%) resulted in an inpatient admission to the same hospital. A similar percentage of females 4.8% and males were admitted 5.8%. The charges for hospital admission were on average $29,431 and had a median of $25,806. This type of analysis is severely limited by the ED’s ability to diagnose FMS and the quality of subsequent coding. These numbers may underestimate ED utilization by FMS patients.

Conclusion: This data gives us valuable information on FMS care in the USA. 16,442 visits to EDs were coded with a principal diagnosis of FMS during the year 2016. Females between the ages 18-64 were the most common to seek ED care for FMS. Patients < 18 years, > 84 years and males were the least likely to visit an ED for FMS. Fortunately only a small fraction of these ED visits led to an inpatient admission to the same hospital.  Even though the overall number of ED FMS visits was small, there seems to be an opportunity to improve coordination of outpatient care to avoid unnecessary ED visits.


FMS ED 2016 ages table 1


FMS ED 2016 GENDER table 2


Disclosure: S. Kambhatla, None; E. Gauto-Mariotti, None; A. MANADAN, None.

To cite this abstract in AMA style:

Kambhatla S, Gauto-Mariotti E, MANADAN A. Emergency Department Utilization for Fibromyalgia Patients [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/emergency-department-utilization-for-fibromyalgia-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/emergency-department-utilization-for-fibromyalgia-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology